Caroline B. Moore

2.9k total citations
49 papers, 2.3k citations indexed

About

Caroline B. Moore is a scholar working on Infectious Diseases, Epidemiology and Small Animals. According to data from OpenAlex, Caroline B. Moore has authored 49 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 37 papers in Epidemiology and 19 papers in Small Animals. Recurrent topics in Caroline B. Moore's work include Antifungal resistance and susceptibility (43 papers), Fungal Infections and Studies (30 papers) and Infectious Diseases and Mycology (17 papers). Caroline B. Moore is often cited by papers focused on Antifungal resistance and susceptibility (43 papers), Fungal Infections and Studies (30 papers) and Infectious Diseases and Mycology (17 papers). Caroline B. Moore collaborates with scholars based in United Kingdom, United States and Austria. Caroline B. Moore's co-authors include David W. Denning, Malcolm Richardson, Susan J. Howard, D. Law, Paul Bowyer, Kevin Oakley, Elizabeth Harrison, Ahmed S. Bueid, S. J. Howard and Juan Alejandro Neira Mosquera and has published in prestigious journals such as JAMA, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Caroline B. Moore

49 papers receiving 2.2k citations

Peers

Countries citing papers authored by Caroline B. Moore

Since Specialization

Citations

This map shows the geographic impact of Caroline B. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline B. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline B. Moore more than expected).

Fields of papers citing papers by Caroline B. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline B. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline B. Moore. The network helps show where Caroline B. Moore may publish in the future.

Co-authorship network of co-authors of Caroline B. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline B. Moore. A scholar is included among the top collaborators of Caroline B. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline B. Moore. Caroline B. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of β-1-3-D-Glucan and Candida Mannan Biomarker Assays with Serological Tests for the Diagnosis of Candidemia 2023 ·Journal of Fungi ·(unknown), (unknown), Jeffrey Lau, Caroline B. Moore, Lilyann Novak Frazer, Malcolm Richardson, Riina Rautemaa‐Richardson	6
2	COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses 2023 ·Microbiology Spectrum ·Matthew E. Mead, Patrícia Alves de Castro, Jacob L. Steenwyk, Jean‐Pierre Gangneux, Martin Hoenigl, Juergen Prattes, Riina Rautemaa‐Richardson, Hélène Guegan, Caroline B. Moore, Cornelia Lass‐Flörl, Florian Reizine, Clara Valero, Norman van Rhijn, Michael Bromley, Antonis Rokas, Gustavo H. Goldman, Sara Gago, (unknown)	3
3	High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum 2019 ·Clinical Microbiology and Infection ·Paschalis Vergidis, Caroline B. Moore, Lilyann Novak Frazer, Riina Rautemaa‐Richardson, A Sarah Walker, David W. Denning, Malcolm Richardson	58
4	A case of pulmonary cryptococcoma due to Cryptococcus gattii in the United Kingdom 2018 ·Medical Mycology Case Reports ·Isabel Rodríguez‐Góncer, Felix Bongomin, Helen Doran, Lilyann Novak Frazer, (unknown), Caroline B. Moore, Malcolm Richardson	6
5	Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA 2017 ·Journal of Microbiological Methods ·Samuel A. Fayemiwo, Caroline B. Moore, Philip Foden, David W. Denning, Malcolm Richardson	25
6	Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis 2012 ·Clinical Microbiology and Infection ·Caroline Baxter, David W. Denning, Andrew Jones, (unknown), Caroline B. Moore, Malcolm Richardson	76
7	Azole Antifungal Resistance Today: Focus on Aspergillus 2011 ·Current Infectious Disease Reports ·Paul Bowyer, Caroline B. Moore, Riina Rautemaa, David W. Denning, Malcolm Richardson	41
8	Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring 2009 ·Clinical Infectious Diseases ·Jodi M. Lestner, Steven A. Roberts, Caroline B. Moore, Susan J. Howard, David W. Denning, William Hope	102
9	Comparison of two fluorescent whiteners, Calcofluor and Blankophor, for the detection of fungal elements in clinical specimens in the diagnostic laboratory 2006 ·Clinical Microbiology and Infection ·(unknown), Caroline B. Moore, David W. Denning	42
10	Adverse Reactions to Voriconazole 2004 ·Clinical Infectious Diseases ·(unknown), Shanu Modi, Susan J. Howard, Caroline B. Moore, Brian Keevil, David W. Denning	142
11	Validation of an Assay for Voriconazole in Serum Samples Using Liquid Chromatography-Tandem Mass Spectrometry 2004 ·Therapeutic Drug Monitoring ·Brian Keevil, Stanton Newman, (unknown), Susan J. Howard, Caroline B. Moore, David W. Denning	64
12	Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) 2003 ·Clinical Microbiology and Infection ·Manuel Cuenca‐Estrella, Caroline B. Moore, Francesco Barchiesi, Jacques Billé, Erja Chryssanthou, David W. Denning, J. Peter Donnelly, Françoise Dromer, B. Dupont, John Rex, Malcolm Richardson, Banu Sancak, Paul E. Verweij, J. L. Rodríguez-Tudela	126
13	In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species† †This study was presented, in part, at the 37th ICAAC in Toronto, Canada, 28th September – 1st October 1997. 2001 ·Clinical Microbiology and Infection ·Caroline B. Moore, Kevin Oakley, David W. Denning	41
14	Antifungal Drug Resistance in Aspergillus 2000 ·Journal of Infection ·Caroline B. Moore, Nicola M. Sayers, Juan Alejandro Neira Mosquera, (unknown), David W. Denning	127
15	Activity of pradimicin BMS-181184 against Aspergillus spp 1999 ·International Journal of Antimicrobial Agents ·(unknown), Caroline B. Moore, David W. Denning	5
16	In Vitro Activity of the Echinocandin Antifungal Agent LY303,366 in Comparison with Itraconazole and Amphotericin B against Aspergillus spp 1998 ·Antimicrobial Agents and Chemotherapy ·(unknown), Caroline B. Moore, David W. Denning	76
17	Candida inconspicua, a Fluconazole‐Resistant Pathogen in Patients Infected with Human Immunodeficiency Virus 1997 ·Clinical Infectious Diseases ·Guy Baily, Caroline B. Moore, (unknown), Stéphane De Wit, J. Burnie, David W. Denning	27
18	Atypical eumycetoma caused by Phialophora parasitica successfully treated with itraconazole and flucytosine 1997 ·British Journal of Dermatology ·Stephen Hood, Caroline B. Moore, J. Cheesbrough, (unknown), David W. Denning	15
19	High incidence of antifungal drug resistance in Candida tropicalis 1996 ·International Journal of Antimicrobial Agents ·D. Law, Caroline B. Moore, Leena Joseph, M.G.L. Keaney, David W. Denning	18
20	High prevalence of antifungal resistance in Candida spp. from patients with AIDS 1994 ·Journal of Antimicrobial Chemotherapy ·D. Law, Caroline B. Moore, (unknown), L A Ganguli, M.G.L. Keaney, David W. Denning	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact